To view the PDF file, sign up for a MySharenet subscription.

ASPEN PHARMACARE HOLDINGS LIMITED - TRADING STATEMENT

Release Date: 09/02/2006 16:51
Code(s): APN
Wrap Text

ASPEN PHARMACARE HOLDINGS LIMITED - TRADING STATEMENT Aspen Pharmacare Holdings Limited ("Aspen") (Incorporated in the Republic of South Africa) (Registration Number 1985/022935/06) Share Code: APN ISIN: ZAE000066692 TRADING STATEMENT Shareholders are advised that Aspen anticipates that headline earnings per share and earnings per share for the six months ended 31 December 2005 (accounted for in terms of International Financial Reporting Standards ("IFRS")) will exceed those of the restated previous interim period ended 31 December 2004 by between 40% and 45%. Headline earnings per share and earnings per share for the comparative period have been restated to comply with IFRS. Had Aspen continued to account for its results in terms of South African GAAP, headline earnings per share and earnings per share would have shown increases of a similar range on the reported results for the six months ended 31 December 2004. The conversion to IFRS has resulted in a reduction in headline earnings per share and earnings per share of between 6% and 8% for both the six month periods ended 31 December 2005 and 31 December 2004. Material items contributing to these reductions are: share-based payment expenses and amortisation on reinstatement of intangible assets previously written off. The financial results on which this trading statement has been based have not been reviewed or reported on by Aspen"s external auditors. Aspen"s interim results are expected to be published on SENS on 27 February 2006. Sandton 9 February 2006 Sponsor: Investec Bank Limited Date: 09/02/2006 04:51:24 PM Supplied by www.sharenet.co.za Produced by the JSE SENS Department

Share This Story